What does this research mean for the field?

Integrating microfluidic systems with size-exclusion chromatography (microSEC) provides an automated, efficient, and cost-effective method for isolating and purifying extracellular vesicles without causing damage, thereby facilitating their clinical translation. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To review microfluidic size-exclusion chromatography (microSEC) as an automated, rapid, and cost-effective approach for isolating undamaged extracellular vesicles for clinical applications.

August 22, 2026Journal of NanobiotechnologyOpen Access

Microfluidic size-based chromatography as a promising label-free tool for isolation and purification of extracellular vesicles

View Full Paper

Ask AI

Bookmark

Authors

MDMaryam Dolatshahi MHMinoo Hosseinimehr NANarges Amiri

Discussion

Member takes

Overview

Narrative review demonstrates the potential of microfluidic size-exclusion chromatography for rapid extracellular vesicle isolation, indicating improved diagnostic and drug delivery capabilities.

Key Points

To review microfluidic size-exclusion chromatography (microSEC) as an automated, rapid, and cost-effective approach for isolating undamaged extracellular vesicles for clinical applications.
Reviewed conventional and emerging isolation methodologies for extracellular vesicles, focusing on microfluidic platforms and size-exclusion chromatography.
Evaluated performance characteristics including labor intensity, processing speed, operational cost, and preservation of vesicle integrity.
Microfluidic size-exclusion chromatography enables automated, label-free isolation that minimizes physical damage to extracellular vesicles compared to conventional bulk methods.
The integrated microSEC approach supports rapid identification of tumor-specific vesicles at the point of care and facilitates downstream applications in targeted drug delivery and personalized medicine.

Cite This Study

Dolatshahi et al. (2026) studied this question.

synapsesocial.com/papers/6a895ec3ca7ade938187cecd https://doi.org/10.1186/s12951-026-04874-5

View Full Paper

Ask AI

Bookmark

August 22, 2026Journal of NanobiotechnologyOpen Access

Microfluidic size-based chromatography as a promising label-free tool for isolation and purification of extracellular vesicles

View Full Paper

Ask AI

Bookmark

Authors

MDMaryam Dolatshahi MHMinoo Hosseinimehr NANarges Amiri

Discussion

Member takes

Overview

Narrative review demonstrates the potential of microfluidic size-exclusion chromatography for rapid extracellular vesicle isolation, indicating improved diagnostic and drug delivery capabilities.

Key Points

To review microfluidic size-exclusion chromatography (microSEC) as an automated, rapid, and cost-effective approach for isolating undamaged extracellular vesicles for clinical applications.
Reviewed conventional and emerging isolation methodologies for extracellular vesicles, focusing on microfluidic platforms and size-exclusion chromatography.
Evaluated performance characteristics including labor intensity, processing speed, operational cost, and preservation of vesicle integrity.
Microfluidic size-exclusion chromatography enables automated, label-free isolation that minimizes physical damage to extracellular vesicles compared to conventional bulk methods.
The integrated microSEC approach supports rapid identification of tumor-specific vesicles at the point of care and facilitates downstream applications in targeted drug delivery and personalized medicine.

Cite This Study

Dolatshahi et al. (2026) studied this question.

synapsesocial.com/papers/6a895ec3ca7ade938187cecd https://doi.org/10.1186/s12951-026-04874-5

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark